Metabolic reprogramming occurs generally downstream of TCR and the co-stimulatory receptor (such as CD28) signaling following interaction between T cells and APCs in autoimmune disease, which activates mTORC1 and MYC signaling. This evidence concerns the gene CD28 and autoimmune disease.